Average Co-Inventor Count = 5.17
ph-index = 3
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. G1 Therapeutics, Inc. (7 from 48 patents)
2. Pharmacosmos Holding A/s (3 from 25 patents)
3. Gi Therapeutics, Inc. (2 from 8 patents)
12 patents:
1. 12497404 - Morphic forms of trilaciclib and methods of manufacture thereof
2. 12479855 - Morphic forms of trilaciclib and methods of manufacture thereof
3. 12264135 - Synthesis of 1,4-diazaspiro[5.5]undecan-3-one
4. 12168666 - Morphic forms of trilaciclib and methods of manufacture thereof
5. 12139494 - Morphic forms of G1T38 and methods of manufacture thereof
6. 11708337 - Synthesis of 1,4-diazaspiro[5.5]undecan-3-one
7. 11629150 - Synthesis of N-(heteroaryl)-pyrrolo[3,2-d]pyrimidin-2-amines
8. 11446295 - Anti-neoplastic combinations and dosing regimens using CDK4/6 inhibitor compounds to treat Rb-positive tumors
9. 11261193 - Morphic forms of G1T38 and methods of manufacture thereof
10. 10988479 - Morphic forms of trilaciclib and methods of manufacture thereof
11. 10865210 - Synthesis of n-(heteroaryl)-pyrrolo[3,2-d]pyrimidin-2-amines
12. 10231969 - Anti-neoplastic combinations and dosing regimens using CDK4/6 inhibitor compounds to treat RB-positive tumors